
Article 1 

1. In addition to the measures taken by Bulgaria in accordance with Articles 4, 5 and 10 of Directive 92/119/EEC, Bulgaria may carry out emergency vaccination against lumpy skin disease of bovine animals kept on holdings in the regions as set out in Annex I hereto in accordance with the conditions set out in Annex II hereto.
2. The programme submitted by Bulgaria to the Commission on 20 May 2016 for the emergency vaccination against lumpy skin disease of bovine animals kept on holdings in the regions set out in Annex I is approved.
3. Any movement to other Member States of bovine animals vaccinated against lumpy skin disease shall be prohibited.
4. Any movement to other Member States of bovine animals younger than six months and not vaccinated against lumpy skin disease but born to dams vaccinated against lumpy skin disease shall be prohibited.
Article 2 
Bulgaria shall take the necessary measures to comply with this Decision and it shall inform the Commission and the other Member States in accordance with Article 19(5) of Directive 92/119/EEC.
Article 3 
The Annex to Implementing Decision (EU) 2016/645 is replaced by the text set out in Annex III to this Decision.
Article 4 
This Decision is addressed to the Republic of Bulgaria.
Done at Brussels, 14 July 2016.
For the Commission
Vytenis ANDRIUKAITIS
Member of the Commission
ANNEX I

Bulgaria:
The following regions in Bulgaria:

— The entire territory of Bulgaria.

ANNEX II

1. Extent of the geographical area in which emergency vaccination is to be carried out The vaccination zone shall be within the regions in Bulgaria described in Annex I to this Decision.The restrictions applicable in the vaccination zone shall be those provided for in this Decision and in Implementing Decision (EU) 2016/645 in addition to those laid down in Article 10 of Directive 92/119/EEC.
2. Species and age of the animals to be vaccinated All bovine animals as defined in Article 2(a) of Implementing Decision (EU) 2016/645 independently of their sex, age and gestational or productive status shall be vaccinated in the first round of vaccination referred to in point 3.Offspring of vaccinated bovine animals shall be vaccinated in accordance with the instructions of the manufacturer when they are four months of age or older.
3. Duration of the vaccination campaign The first round of vaccination in the affected areas shall be completed by 30 June 2016.The first round of vaccination in the remaining areas of the region listed in Annex I shall be completed as soon as possible and not later than two months after the confirmation of the first outbreak in that area.
4. Specific standstill of animals and products thereof Irrespective of any other measures that may be in place in the restricted zone as defined in Implementing Decision (EU) 2016/645, bovine animals older than 90 days shall not be moved to another holding except if they were vaccinated and regularly re-vaccinated at least 28 days before the date of the movement.Upon expiry of the period of 28 days after the date of the vaccination, the measures for the movement of vaccinated bovine animals and for the placing on the market of products derived from vaccinated bovine animals as laid down in Implementing Decision (EU) 2016/645 shall apply in addition to those laid down in Article 10 of Directive 92/119/EEC.Unvaccinated bovine animals may be moved for direct slaughter to a slaughterhouse situated within the restricted zone. Except in the case of emergency slaughter, a waiting period of seven days after vaccination in the herd shall be observed before unvaccinated bovine animals from holdings on which vaccination was carried out are sent for slaughter.Unvaccinated offspring younger than six months born to and fed the colostrum of dams vaccinated at least 28 days prior to labour may be moved to another holding situated within the restricted zone.
5. Special registration of the vaccinated animals For each vaccinated bovine animal vaccination details shall be entered by the local competent authority in the dedicated online database connected with the central database established in accordance with Regulation (EC) No 1760/2000 of the European Parliament and of the Council.The records must ensure a link between the vaccinated dam and the offspring.
6. Other matters appropriate to the emergency vaccination
6.1. Surveillance area in Bulgaria surrounding the vaccination zone A surveillance area of at least 10 km around the vaccination zone referred to in point 1 shall be established, in which intensified surveillance shall be carried out and the movement of bovine animals shall be subject to controls by the competent authority.Bovine animals not vaccinated against LSD and kept on holdings situated in the surveillance area surrounding the vaccination zone shall not leave their holdings until a waiting period of at least seven days has elapsed following the completion of the vaccination on holdings situated in the vaccination zone at a distance of less than 10 km.
6.2. Period for which the measures applied in the zones established in accordance with Article 10 of Directive 92/119/EEC and Implementing Decision (EU) 2016/645 are maintained The measures applied in the vaccination zone shall remain in force until they are abrogated in accordance with Article 19(6) of Directive 92/119/EEC.
6.3. Execution of the vaccination campaign Vaccination shall be carried out by an official of the competent authority or a private veterinarian appointed by and under the supervision of the competent authority.The priority for vaccination shall be given to the bovine animals kept on holdings situated within the protection and surveillance zones and in areas bordering other Member States and regions in Bulgaria which are free of LSD.The necessary measures shall be in place to avoid the spread of possible virus. Any residual quantities of vaccine shall be returned to the point of vaccine distribution with a written record on the number of bovine animals vaccinated and the number of doses used.
6.4. Vaccine to be used Homologous live attenuated virus vaccine against LSD (Neethling strain), ‘Lumpy skin disease vaccine for cattle’, Onderstepoort Biological Products, South Africa.Alternatively: live attenuated virus vaccine against LSD (SIS type), ‘Lumpyvax’, MSD Animal Health, Intervet, South Africa.The vaccine shall be used in accordance with the instructions of the manufacturer and Article 8 of Directive 2001/82/EC under the responsibility of the central competent authorities.
6.5. Progress Reports and Final Report A progress report on the execution of the emergency vaccination programme shall be provided to the Commission and the Member States in accordance with Article 19(5) of Directive 92/119/EEC.A detailed report on the completion of the emergency vaccination programme shall be provided to the Commission and the Member States in accordance with Article 19(5) of Directive 92/119/EEC before the restrictions referred to in points 6.1 and 6.2 of this Annex are removed.

ANNEX III

The Annex to Implementing Decision (EU) 2016/645 is replaced by the following:

‘ANNEX Bulgaria:
The following regions in Bulgaria:

— The entire territory of Bulgaria’.

